Risk of incident type 2 diabetes with romosozumab versus denosumab in patients with osteoporosis: A global real-world cohort study

Diabetes & Metabolism · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles